Want to see HK:2112 full AI Analyst Report?
Top Page
Grace Life-tech Holdings Limited
(2112)
Select Model
Select Model
Rating:41Neutral
Price Target:
HK$0.03
▼(-20.00% Downside)
Action:Reiterated
Date:10/21/26
The score is driven primarily by very weak financial fundamentals (persistent losses, negative equity, and negative cash flows), which materially elevate funding and execution risk. Technicals are also broadly weak with the price below major moving averages, despite some neutral-to-slightly-positive momentum readings. Valuation provides limited support because earnings are negative and no dividend yield is available.
Positive Factors
Positive Gross Margin
A positive gross margin indicates the company retains some contribution from its distribution activities after direct costs. Although insufficient to cover operating expenses today, this provides a base for potential operating improvement if revenue stabilizes and overhead is brought into line with the business scale.
Negative Factors
Persistent Losses and Shrinking Revenue
Repeated annual net losses combined with another material revenue decline indicate that the current business model has not established a stable earnings base. Continued contraction can weaken operating leverage, limit reinvestment capacity, and make a durable return to profitability more difficult without meaningful business improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Positive Gross Margin
A positive gross margin indicates the company retains some contribution from its distribution activities after direct costs. Although insufficient to cover operating expenses today, this provides a base for potential operating improvement if revenue stabilizes and overhead is brought into line with the business scale.
Read all positive factors
Grace Life-tech Holdings Limited (2112) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$48.00M
Dividend Yield3.07%
Average Volume (3M)650.07K
Price to Earnings (P/E)―
Beta (1Y)0.53
Revenue Growth-45.65%
EPS Growth29.13%
CountryHK
Employees46
SectorBasic Materials
Sector Strength58
IndustryIndustrial - Distribution
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,500,000,000
10 Day Avg. Volume1,170,400
30 Day Avg. Volume650,066
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-0.06
Price to Sales (P/S)0.86
P/FCF Ratio-30.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Grace Life-tech Holdings Limited Business Overview & Revenue Model
Company Description
Grace Life-tech Holdings Limited, an investment holding company, engages in the research, development, and application of plant stem cell technology. It is also involved in the provision of health solutions and product sales in Hong Kong, the Peop...
Grace Life-tech Holdings Limited Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
8
Very Negative
Cash Flow
10
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.78M | 13.06M | 13.76M | 27.25M | 32.35M | 23.98M |
| Gross Profit | 1.18M | 1.48M | 2.17M | 2.85M | 2.54M | 164.00K |
| EBITDA | -8.00M | -7.50M | -30.49M | -23.74M | -42.55M | -44.21M |
| Net Income | -27.50M | -15.44M | -48.13M | -39.57M | -55.74M | -57.01M |
Balance Sheet | ||||||
| Total Assets | 77.60M | 75.50M | 79.80M | 108.95M | 133.56M | 173.13M |
| Cash, Cash Equivalents and Short-Term Investments | 129.98K | 358.95K | 255.00K | 135.00K | 187.00K | 1.19M |
| Total Debt | 161.26M | 148.27M | 193.26M | 121.04M | 171.57M | 166.50M |
| Total Liabilities | 271.23M | 257.10M | 247.29M | 228.85M | 213.88M | 197.41M |
| Stockholders Equity | -193.43M | -181.42M | -167.40M | -119.90M | -80.32M | -24.27M |
Cash Flow | ||||||
| Free Cash Flow | -4.43M | -372.55K | -78.00K | -53.00K | -1.01M | 1.10M |
| Operating Cash Flow | -4.43M | -372.55K | -75.00K | -27.00K | -1.00M | 1.41M |
| Investing Cash Flow | 0.00 | 0.00 | -3.00K | -26.00K | -2.00K | -303.00K |
| Financing Cash Flow | 4.48M | 488.72K | 193.00K | 0.00 | 0.00 | -12.00K |
Grace Life-tech Holdings Limited Technical Analysis
Negative
0.04
Price Trends
0.04
Negative
0.04
Negative
0.06
Negative
Market Momentum
>-0.01
Positive
22.01
Positive
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2112, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 22.01 is Positive, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2112.
Grace Life-tech Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$860.85M | 14.61 | 2.08% | 3.05% | 16.60% | -12.13% | |
45 Neutral | HK$3.58B | -191.93 | -8.09% | 2.18% | 3.15% | 50.74% | |
43 Neutral | HK$305.15M | -12.37 | -634.56% | ― | 53.32% | -122.35% | |
41 Neutral | HK$48.00M | -0.22 | 14.68% | 3.07% | -45.65% | 29.13% |
* Basic Materials Sector Average
HK:2112
Grace Life-tech Holdings Limited
0.03
-0.03
-49.21%
HK:8189
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H
0.14
-0.25
-63.33%
HK:0609
Tiande Chemical Holdings Limited
0.98
-0.38
-28.10%
HK:0301
SANVO Fine Chemicals Group Limited
7.60
6.35
508.00%
HK:0660
Wai Chun Bio-Technology Ltd.
0.43
0.22
100.00%
HK:2565
PegBio Co., Ltd. Class H
4.09
-56.02
-93.20%
Grace Life-tech Holdings Limited Corporate Events
Grace Life-tech Publishes 2026 Interim Results Amid Ongoing Restructuring
Aug 31, 2026
Grace Life-tech Holdings Limited has released its unaudited interim results for the six months ended 30 June 2026, fulfilling Hong Kong listing requirements despite being under restructuring with joint provisional liquidators in place. The interim...
Grace Life-tech Sets August Board Meeting to Approve Interim Results and Consider Dividend
Aug 18, 2026
Grace Life-tech Holdings Limited has scheduled a board meeting for 31 August 2026 to review and approve the interim results of the company and its subsidiaries for the six months ended 30 June 2026. The board will also consider the declaration of ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.